Genelux (GNLX) News Today → Trump convicted... now what? (From Stansberry Research) (Ad) Free GNLX Stock Alerts $2.30 +0.02 (+0.88%) (As of 09:32 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 9 at 10:23 PM | marketbeat.comWoodward Diversified Capital LLC Boosts Stock Holdings in Genelux Co. (NASDAQ:GNLX)Woodward Diversified Capital LLC increased its stake in Genelux Co. (NASDAQ:GNLX - Free Report) by 2,326.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,082,270 shares of the company's stock after buying an additionaJune 4, 2024 | americanbankingnews.comShort Interest in Genelux Co. (NASDAQ:GNLX) Increases By 5.2%June 3, 2024 | marketbeat.comGenelux Co. (NASDAQ:GNLX) Short Interest UpdateGenelux Co. (NASDAQ:GNLX - Get Free Report) was the target of a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 2,440,000 shares, an increase of 5.2% from the April 30th total of 2,320,000 shares. Based on an average trading volume of 190,100 shares, the short-interest ratio is currently 12.8 days. Approximately 12.1% of the company's shares are short sold.June 1, 2024 | americanbankingnews.comGenelux (NASDAQ:GNLX) Price Target Lowered to $25.00 at BenchmarkMay 31, 2024 | marketbeat.comGenelux (NASDAQ:GNLX) Price Target Cut to $25.00 by Analysts at BenchmarkBenchmark dropped their price objective on Genelux from $30.00 to $25.00 and set a "speculative buy" rating for the company in a research note on Friday.May 24, 2024 | msn.comWhy Genelux Corporation (GNLX) Shares Are Down 40%May 24, 2024 | globenewswire.comGenelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying WarrantsMay 23, 2024 | globenewswire.comGenelux Corporation Announces Proposed Public Offering of Common Stock and WarrantsMay 16, 2024 | finance.yahoo.comGenelux Corporation (GNLX)May 16, 2024 | insidertrades.comInsider Selling: Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells 3,446 Shares of StockMay 15, 2024 | marketbeat.comGenelux Co. (NASDAQ:GNLX) Major Shareholder Sells $12,474.52 in StockGenelux Co. (NASDAQ:GNLX - Get Free Report) major shareholder Aladar Szalay sold 3,446 shares of the business's stock in a transaction on Monday, May 13th. The stock was sold at an average price of $3.62, for a total transaction of $12,474.52. Following the completion of the sale, the insider now owns 1,172,341 shares of the company's stock, valued at $4,243,874.42. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Large shareholders that own at least 10% of a company's stock are required to disclose their transactions with the SEC.May 13, 2024 | marketbeat.comGenelux's (GNLX) "Buy" Rating Reiterated at HC WainwrightHC Wainwright restated a "buy" rating and set a $32.00 price objective on shares of Genelux in a research report on Monday.May 11, 2024 | markets.businessinsider.comBuy Rating Affirmed for Genelux Corp on Strong Trial Progress and Solid FinancialsMay 10, 2024 | insidertrades.comInsider Selling: Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells 6,025 Shares of StockMay 10, 2024 | investorplace.comGNLX Stock Earnings: Genelux Misses EPS for Q1 2024May 9, 2024 | marketbeat.comAladar Szalay Sells 6,025 Shares of Genelux Co. (NASDAQ:GNLX) StockGenelux Co. (NASDAQ:GNLX - Get Free Report) major shareholder Aladar Szalay sold 6,025 shares of the firm's stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $3.67, for a total transaction of $22,111.75. Following the completion of the sale, the insider now owns 1,189,706 shares in the company, valued at $4,366,221.02. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Major shareholders that own more than 10% of a company's stock are required to disclose their sales and purchases with the SEC.May 9, 2024 | globenewswire.comGenelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business UpdatesMay 5, 2024 | finance.yahoo.comGenelux Corporation's (NASDAQ:GNLX) market cap rose US$11m last week; individual investors who hold 54% profited and so did insidersMay 2, 2024 | insidertrades.comGenelux Co. (NASDAQ:GNLX) Major Shareholder Sells $20,809.75 in StockMay 2, 2024 | insidertrades.comInsider Selling: Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells 33,061 Shares of StockApril 25, 2024 | insidertrades.comInsider Selling: Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells 8,064 Shares of StockApril 20, 2024 | investing.comGenelux Corp insider sells shares worth over $250kApril 19, 2024 | insidertrades.comGenelux Co. (NASDAQ:GNLX) Major Shareholder Aladar Szalay Sells 48,683 SharesApril 17, 2024 | msn.comGenelux (GNLX) Price Target Decreased by 22.96% to 26.52April 14, 2024 | marketbeat.comVanguard Group Inc. Buys 925,258 Shares of Genelux Co. (NASDAQ:GNLX)Vanguard Group Inc. boosted its stake in shares of Genelux Co. (NASDAQ:GNLX - Free Report) by 1,660.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 980,993 shares of the company's stock after buyinApril 4, 2024 | marketbeat.comResearch Analysts Set Expectations for Genelux Co.'s Q1 2024 Earnings (NASDAQ:GNLX)Genelux Co. (NASDAQ:GNLX - Free Report) - Research analysts at HC Wainwright issued their Q1 2024 earnings estimates for shares of Genelux in a note issued to investors on Tuesday, April 2nd. HC Wainwright analyst E. Bodnar expects that the company will post earnings per share of ($0.26) for theApril 3, 2024 | marketbeat.comGenelux's (GNLX) "Speculative Buy" Rating Reiterated at BenchmarkBenchmark restated a "speculative buy" rating and set a $30.00 price objective on shares of Genelux in a research report on Wednesday.April 3, 2024 | marketbeat.comBrokers Set Expectations for Genelux Co.'s FY2028 Earnings (NASDAQ:GNLX)Genelux Co. (NASDAQ:GNLX - Free Report) - Research analysts at HC Wainwright issued their FY2028 EPS estimates for shares of Genelux in a research report issued to clients and investors on Tuesday, April 2nd. HC Wainwright analyst E. Bodnar expects that the company will earn $0.82 per share for tApril 2, 2024 | marketbeat.comHC Wainwright Lowers Genelux (NASDAQ:GNLX) Price Target to $32.00HC Wainwright cut their price objective on Genelux from $35.00 to $32.00 and set a "buy" rating on the stock in a research report on Tuesday.April 2, 2024 | investorplace.comGNLX Stock Earnings: Genelux Misses EPS for Q4 2023April 1, 2024 | globenewswire.comGenelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateMarch 19, 2024 | seekingalpha.comAtossa climbs after cancer therapy updateMarch 15, 2024 | msn.comTD Cowen cuts Immuneering to market perform, cites Phase 1 dataMarch 15, 2024 | marketbeat.comShort Interest in Genelux Co. (NASDAQ:GNLX) Expands By 30.3%Genelux Co. (NASDAQ:GNLX - Get Free Report) was the target of a significant increase in short interest in the month of February. As of February 29th, there was short interest totalling 1,590,000 shares, an increase of 30.3% from the February 14th total of 1,220,000 shares. Currently, 8.1% of the company's stock are short sold. Based on an average daily volume of 125,100 shares, the days-to-cover ratio is presently 12.7 days.March 10, 2024 | msn.comCytomX FY 2023 Earnings PreviewMarch 5, 2024 | marketbeat.comShort Interest in Genelux Co. (NASDAQ:GNLX) Rises By 9.9%Genelux Co. (NASDAQ:GNLX - Get Free Report) was the target of a large increase in short interest in the month of February. As of February 15th, there was short interest totalling 1,220,000 shares, an increase of 9.9% from the January 31st total of 1,110,000 shares. Currently, 6.2% of the company's shares are short sold. Based on an average trading volume of 132,200 shares, the short-interest ratio is presently 9.2 days.February 23, 2024 | benzinga.comGenelux Stock (NASDAQ:GNLX) Insider TradesFebruary 12, 2024 | msn.comG1 Therapeutics stock dives 36% post-market on P3 study updateFebruary 6, 2024 | msn.comGenelux Corp. Unveils Future-Oriented Corporate PresentationFebruary 3, 2024 | msn.comGenelux Corp. Estimates $23.2 Million in Year-End AssetsJanuary 23, 2024 | finance.yahoo.comHealthcare IT Leaders Adds Health Industry Veteran Mary Mirabelli to Board of DirectorsJanuary 2, 2024 | marketbeat.comShort Interest in Genelux Co. (NASDAQ:GNLX) Rises By 11.1%Genelux Co. (NASDAQ:GNLX - Get Free Report) was the target of a large growth in short interest in December. As of December 15th, there was short interest totalling 889,700 shares, a growth of 11.1% from the November 30th total of 801,000 shares. Based on an average daily volume of 143,900 shares, the short-interest ratio is currently 6.2 days. Currently, 4.5% of the company's stock are sold short.December 24, 2023 | marketbeat.comAE Wealth Management LLC Has $4.77 Million Stock Position in Genelux Co. (NASDAQ:GNLX)AE Wealth Management LLC lifted its position in shares of Genelux Co. (NASDAQ:GNLX - Free Report) by 1,370.0% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 194,875 shares of the company's stock after buying an additional 181,618 sharesDecember 21, 2023 | benzinga.comGenelux Stock (NASDAQ:GNLX) Dividends: History, Yield and DatesDecember 15, 2023 | finance.yahoo.comInsider Sell Alert: Director James Tyree Offloads 9,000 Shares of Genelux Corp (GNLX)December 14, 2023 | marketbeat.comGenelux Co. (NASDAQ:GNLX) Director John Thomas Sells 9,000 SharesGenelux Co. (NASDAQ:GNLX - Get Free Report) Director John Thomas sold 9,000 shares of the business's stock in a transaction that occurred on Wednesday, December 13th. The stock was sold at an average price of $13.38, for a total value of $120,420.00. Following the sale, the director now owns 463,460 shares of the company's stock, valued at approximately $6,201,094.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.November 27, 2023 | msn.comHC Wainwright & Co. Initiates Coverage of Genelux (GNLX) with Buy RecommendationNovember 27, 2023 | msn.comGenelux gets fast track status for Olvi-Vec in ovarian cancerNovember 27, 2023 | msn.comHC Wainwright starts Genelux at buy, cites Olvi-Vec potentialNovember 27, 2023 | markets.businessinsider.comGenelux Says FDA Grants Fast Track Designation For Olvi-Vec To Treat Ovarian Cancer Get Genelux News Delivered to You Automatically Sign up to receive the latest news and ratings for GNLX and its competitors with MarketBeat's FREE daily newsletter. Email Address It's time to ween off Chinese lithium! (Ad)As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closely Learn how this American company is leading the lithium-ion revolution GNLX Media Mentions By Week GNLX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNLX News Sentiment▼1.560.76▲Average Medical News Sentiment GNLX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNLX Articles This Week▼31▲GNLX Articles Average Week Get Genelux News Delivered to You Automatically Sign up to receive the latest news and ratings for GNLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CorMedix News Nature's Sunshine Products News Mersana Therapeutics News ADC Therapeutics News 23andMe News Adlai Nortye News Enanta Pharmaceuticals News Atai Life Sciences News Aquestive Therapeutics News Immutep News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GNLX) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredTrump convicted... now what?Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored